Skip to main content

Table 1 Comparison of age, anthropometric parameters and peak GH levels after provocation in the 3 studied groups (IGHD, ISS and SGA) (no. = 40)

From: Growth hormone therapy response in children with short stature

Characteristics

IGHD (n = 21)

ISS (n = 8)

SGA (n = 11)

p value

Initial age (years)

12.56 ± 2.71

13.75 ± 3.52

11.34 ± 2.99

0.163

Initial height (cm)

129.1 ± 13.62

133.95 ± 17.21

123.27 ± 15.7

0.322

Initial height SD

-3.46 ± 0.58

-3.39 ± 0.56

-3.42 ± 0.78

0.931

Initial weight (kg)

29.57 ± 9.51

32.69 ± 12.92

26.73 ± 9.54

0.531

Initial weight SD

-2.56 ± 1.12

-2.875 ± 1.03

-2.51 ± 1.061

0.704

Maternal height (cm)

153.69 ± 3.65

155.25 ± 6.09

155.59 ± 5.63

0.729

Paternal height (cm)

166.88 ± 6.39

163.5 ± 6.46

167.77 ± 6.95

0.38

MPH (cm)

164.51 ± 7.3

164.06 ± 8.31

164.7 ± 9.3

0.901

MPH SD

-0.99 ± 0.398

-1.07 ± 0.52

-0.85 ± 0.55

0.359

Initial bone age (years)

8.84 ± 3.12

10.68 ± 2.095

8.3 ± 3.55

0.282

Peak GH in Clonidine test(ng/ml)

3.18 ± 1.53

12.66 ± 4.14

6.34 ± 6.02

ND

Peak GH in ITT (ng/ml)

3.28 ± 1.89

10.8 ± 6.24

4.89 ± 6.82

ND

  1. Cm Centimetre, SD Standard deviation, ng Nanograms, ml Millilitre, MPH Mid-parental height, GH Growth hormone, ITT Insulin tolerance test, IGHD Idiopathic growth hormone deficiency, ISS Idiopathic short stature, SGA Small for gestational age, ND Not determined